Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
As filed · Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
RegulatoryWatchNotablemateriality 61 out of 100
What happened
FactGujarat Themis Biosyn Limited has initiated arbitration proceedings against Optimus Drugs Private Limited due to the termination of a supply agreement, claiming a total of approximately Rs. 90,80,849, which includes break fees, interest on delayed payments, and damages. The company does not expect any financial implications from penalties related to this arbitration. This disclosure is made in accordance with SEBI regulations.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Watch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- The transaction is expected to close by the end of Q3FY27 (Quarter Ending 31st December 2026), subject to cust (management committed by Q3 FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%